相关实验视频

Updated: Jun 5, 2025

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.7K

在帕金森病中反射眼的萨卡迪式参数.

Nemuel D Pah1,2, Quoc C Ngo1, Nicole McConnell3

  • 1School of Engineering, RMIT University, Melbourne, VIC, Australia.

Frontiers in medical technology
|December 10, 2024
PubMed
概括

与年龄匹配对照组 (AMC) 相比,患有帕金森病 (PwPD) 的人表现出明显的反射形模式,包括较短的延迟和增加的超越,与年龄匹配对照组 (AMC) 相比. 这些眼睛和眼神之间的差异,可以通过负担得起的技术进行测量,有助于早期评估帕金森病.

关键词:
帕金森病是帕金森氏症的一种疾病.眼睛看着眼睛看着眼睛延迟时间 延迟时间反射的萨卡德是一个反射的萨卡德.在萨卡迪克 (saccadic) 地区.

更多相关视频

Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram06:12

Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram

Published on: March 13, 2018

10.6K
Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function05:44

Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function

Published on: July 14, 2016

7.4K

相关概念视频

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
219
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
479